Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition. On February 27, 2026, Fulgent Genetics, Inc. (the “Company”) issued a press release announcing its financial resu
Regulation FD Disclosure. From time to time, the Company presents and/or distributes slides and presentations to the investment community to provide updates and
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release of Fulgent Genetics, Inc., dated February 27, 2026 99.2 Corporate Pr